Seed Media Group

Profile

sidebarphoto.jpg bioephemera is art + biology - anything and everything from representations of science in art and literature to the neuroscience of aesthetics. Along with lots of other stuff that's just plain interesting.

Jessica Palmer is a biologist & artist currently based in Washington, DC. She spent the last few years teaching at a small state college out West, and now plays with science policy. Her homepage includes the bioephemera archives & a gallery of her work.

Note: the contents of this blog are the personal opinions of the author, completely independent of any organizations with which she is affiliated.

Search this blog

Recent Posts

Categories

Recent Comments

bioephemeral sampler

Archives

Blogroll

Shiny Objects

00ootssoeraaapsmall.jpg
thinkingbloggerpf8.jpg
intellectual-blogger-award-small-thumb.jpg
excellentblog.jpg
My Amazon.com Wish List

Recently Read

« Athanasius Kircher, MIA? | Main | Wordlerizing Darwin, Watson and Crick »

Office of Technology Assessment (OTA) Online Archive

Category: BiologyBooksEducationScienceScience in Culture & Policy
Posted on: July 23, 2008 12:45 PM, by Jessica Palmer

Today FAS put up an online public archive of documents produced by the Office of Technology Assessment.

As you may know, the OTA was a legislative office authorized in 1972 to produce comprehensive nonpartisan reports for Congress on a variety of scientific topics. It was defunded and closed in 1995, and the bulky paper reports it produced have been rather hard to find. Although these reports no longer represent the state of the science, they are remarkable, often prescient time capsules - a fascinating look at how teams of experts tried to predict the trajectory of new technologies we now take for granted.

For example, "Commercial Biotechnology, An International Analysis" (1984) predicts that Japan, Germany, the UK, Switzerland and France will be our major competitors in biotechnology, adding,

Because of the rapid diffusion of the new genetic techniques into pharmaceutical R&D programs, the pharmaceutical sector is currently most active in commercializing biotechnology. For this reason, it serves as a model for the industrial development of biotechnology in much of this report. It is important to recognize, however, that the development of biotechnology in other industrial sectors will differ from its development in the pharmaceutical sector. Regulatory and trade barriers and a marketing and distribution system unique to the pharmaceutical sector limit its usefulness as a model. Furthermore, the techniques may not diffuse as rapidly into other industrial sectors, such as the chemical industry, because of difficulties companies may have in recovering investments in R&D and physical plants required to convert to biological methods of production. . . As more is learned about hormone growth factors, immune regulators, and neurological peptides, their importance in the treatment of disease may increase dramatically. Eventually, the production of such regulatory proteins may turn out to be the largest application of biotechnology in the pharmaceutical industry.

Not too bad.

The OTA archive has actually been available through Princeton for some time, along with a collection of articles about the office and its demise. This new attention to the archive coincides with a political movement to reinstate the OTA. The FAS site is obviously in favor of doing so; it features an interview with Congressman Rush Holt of New Jersey about why the OTA would be essential today, perhaps even more so than in previous decades.

Post a Comment

(Email is required for authentication purposes only. Comments are moderated for spam, your comment may not appear immediately. Thanks for waiting.)





Having problems commenting? (UPDATED)

Blogs in the Network

Advertisement

Top Five: Most Active

  1. Jon Stewart is brilliant 09.05.2008 · PZ Myers
  2. Say…what about Molly? 09.05.2008 · PZ Myers
  3. More Law Enforcement Militarization 09.06.2008 · Ed Brayton
  4. Hell hath no fury like Joe Biden. Or so we hope. 09.05.2008 · Greg Laden
  5. You can't make this stuff up 09.05.2008 · Tim Lambert

Search All Blogs